Is there a role for breast cancer screening in male BRCA carriers?
Research type
Research Study
Full title
Is There a Role for Breast Cancer Screening in Male BRCA Carriers? An Exploration of Factors Influencing Uptake.
IRAS ID
202726
Contact name
Judi Curtis
Contact email
Sponsor organisation
Kingston University & St Georges Joint Faculty
Duration of Study in the UK
0 years, 4 months, 8 days
Research summary
The research question being addressed is 'Is There a Role for Breast Cancer Screening in Male BRCA Carriers? An Exploration of Factors Influencing Uptake'.
It is relevant and important to both patients and the public as there is inequity between breast screening provision for women and men with an increased risk of breast cancer through family history. Currently there is a familial history mammography breast screening programme for women but not for men.
The area to be studied is whether men with a proven hereditary defective breast cancer gene (BRCA) would attend a mammography breast screening programme for earlier detection of male breast cancer. There will be an exploration of the factors which would influence men to attend or not to attend for mammography breast screening and why and from this an assessment of the feasibility of a breast screening programme for this group of men.
The criteria for eligibility is males over 18 years of age who are known to the local Clinical Genetics centre, have a proven defective breast cancer gene (BRCA) which is hereditary and have not previously had breast cancer.
The study will be conducted in collaboration with a regional Clinical Genetics centre within an NHS Foundation Trust teaching hospital.
The study will last for approximately six months in total and participants will receive a covering letter from Clinical Genetics, either when they attend the clinic or by post inviting them to participate in the research study. There will be a Participant Information sheet from the researcher and if interested participants will sign the Consent form and complete and sign the questionnaire with both 'closed' and 'open' answers and return to Clinical Genetics. Only the direct care team will have access to personal data, the questionnaire will be anonymised and allocated a random number prior to researcher data analysis.REC name
Wales REC 7
REC reference
16/WA/0220
Date of REC Opinion
3 Aug 2016
REC opinion
Further Information Favourable Opinion